Lola Olufemi

Lola Olufemi, Ph.D.

Technology Portfolio Manager

Dr. Lola Olufemi, Technology Portfolio Manager

Dr. Lola Olufemi manages the agreement and invention portfolio for investigators in the Surgical Neurology Branch, Clinical Epilepsy section, Stroke Branch, and Biochemistry Branch of NINDS. She negotiates Cooperative Research and Development Agreements (CRADAs), Clinical Trial Agreements (CTA), Research Collaboration Agreements (RCAs), Material Transfer Agreements (MTAs), disclosure agreements and licenses. She negotiates agreements with entities both in the U.S. and abroad ranging from pharmaceutical companies, non-profits and academic institutions.   She also manages invention evaluations and patent prosecution for patent application filings.  Dr. Olufemi is passionate about increasing participation in STEM areas.  She actively participates in NINDS initiatives that encourage students’ participation in STEM areas including NINDS National Week at the Labs, NINDS Summer Research Poster Presentation, Brains R Us, and the Brain Lobe-oratorium featured at the annual Science and Engineering Festival. 

Dr. Olufemi completed her doctoral degree in Molecular Biology, Biochemistry and Microbiology at Southern Illinois University, School of Medicine.  She was awarded the National Science Foundation (NSF) Bridge to Doctorate fellowship. During her graduate studies, she also worked as a contributing writer for the American Society for Biochemistry and Molecular Biology.  She later went on to Emory University where she pursued her post-doctoral training in Biochemistry while interning in Emory’s Office of Technology Transfer.  She served as a Co-Chair in the Emerging Leaders Network of Georgia Bio.  Dr. Olufemi later went on to work as a Technology Transfer Specialist in CDC’s Technology Transfer Office. While at CDC, Dr. Olufemi managed agreement portfolios within the National Center of HIV, Viral Hepatitis, STDs, and Tuberculosis Prevention (NCHHSTP), National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), and National Center for Immunization and Respiratory Diseases (NCIRD). She developed a new, web adapted agreement for the FDA-CDC Bacterial Isolate Repository to provide diagnostic manufacturers bacterial isolates for the validation of their devices. She also contributed to the establishment of the invention assessment process, development of marketing strategies, and the launch of the CDC TTO website.